adapted applicant s university puerto rico upr actu unit accrued significant numbers patients several important clinical trials developed infrastructure group last 36 months upr adult actu participated 18 different actg trials total 231 new patients accrued participate substudies patients hispanics stratified follows 36 percent females 65 percent males 216 percent injection drug users idu upr adult actu plans immediate research collaboration pharmacy research section perform phase ii pharmacokinetic pk intracellular concentration trials well clinical trials naive heavily pretreated individuals women idus embark important aspects metabolic complications novel approaches immunological enhancers among others upr actu part actg offers opportunity variation patterns epidemiological clinical manifestations aids minority groups also provides much needed supportive therapeutic alternatives patients